
OpenEvidence
$540.41
Source:$21.39 (4.12%)past six months
OpenEvidence Valuation
Follow estimated valuations, share price trends, and company updates for OpenEvidence.
About OpenEvidence
OpenEvidence delivers an AI-driven platform that helps healthcare professionals effortlessly explore and understand medical research. It synthesizes peer-reviewed clinical studies and multimedia into digestible insights that support informed decision making at the point of care. The platform seamlessly integrates evidence-based content into clinicians’ workflows to enhance patient outcomes.
| Co-Founder | Zachary Ziegler |
| CEO | Daniel Nadler |
| CTO | Zachary Ziegler |
| Headquarters | Cambridge, MA |
| Founded | 2019 |
| Sector | Healthcare & Life Sciences |
OpenEvidence Funding History
| Financing Round | Date | Amount |
|---|---|---|
| Series D-3 | Sep 24, 2026 | $230M |
| Series D | Jan 21, 2026 | $225M |
| Series C-2 | Oct 20, 2025 | $75M |
| Series C-2 | Oct 20, 2025 | $125M |
| Series B-1 | Jul 15, 2025 | $30M |
| Series B-1 | Jul 15, 2025 | $125M |
OpenEvidence lead investors
- Andreessen Horowitz
- Blackstone
- BOND
- Coatue
- Craft Ventures
- DST Global
- Google Ventures
- Greycroft
- Kleiner Perkins Caufield & Byers
- Sequoia
- Thrive Capital
FAQ
Frequently asked questions
OpenEvidence's estimated secondary market share price is $540.41 as of September 2026.
OpenEvidence's last official round, Series D-3, was for $230M.
OpenEvidence's last known funding was on Sep 24, 2026 for $230M.
OpenEvidence's major investors are Andreessen Horowitz, Blackstone, BOND, Coatue, Craft Ventures, DST Global, Google Ventures, Greycroft, Kleiner Perkins Caufield & Byers, Sequoia, Thrive Capital.
As of October 16, 2026, OpenEvidence is not yet publicly traded.
Private companies
OpenAIOPEA+25.12%
StripeSTRI+3.79%
DatabricksDABR+32.49%
AnthropicANTH+130.28%
PerplexityPERP+20.22%
NeuralinkNEUL+49.94%
AndurilADUI+14.48%
OpenEvidence Valuation
Follow estimated valuations, share price trends, and company updates for OpenEvidence.
Private companies
OpenAIOPEA+25.12%
StripeSTRI+3.79%
DatabricksDABR+32.49%
AnthropicANTH+130.28%
PerplexityPERP+20.22%
NeuralinkNEUL+49.94%
AndurilADUI+14.48%